Post-stroke Movement Disorders: Clinical Spectrum, Pathogenesis, and Management.
Tater P, Pandey S.
Neurol India. 2021 Mar-Apr;69(2):272-283. doi: 10.4103/0028-3886.314574.
PMID:33904435
Movement Disorder Emergencies.
Apetauerova D, Patel PA, Burns JD, Lerner DP.
Neurol Clin. 2021 May;39(2):615-630. doi: 10.1016/j.ncl.2021.01.005. Epub 2021 Mar 31.
PMID:33896535
Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force - An Update.
Lange LM, Gonzalez-Latapi P, Rajalingam R, Tijssen MAJ, Ebrahimi-Fakhari D, Gabbert C, Ganos C, Ghosh R, Kumar KR, Lang AE, Rossi M, van der Veen S, van de Warrenburg B, Warner T, Lohmann K, Klein C, Marras C; on behalf of the Task Force on Genetic Nomenclature in Movement Disorders.
Lamotrigine-Associated Movement Disorder: A Literature Review.
Rissardo JP, Fornari Caprara AL.
Neurol India. 2021 Nov-Dec;69(6):1524-1538. doi: 10.4103/0028-3886.333440.
PMID:34979637
Cocaine-induced Movement Disorder: A Literature Review.
Byroju VV, Rissardo JP, Durante Í, Caprara ALF.
Prague Med Rep. 2024;125(3):195-219. doi: 10.14712/23362936.2024.19.
PMID:39171548
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.
Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L; Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease.